Research Paper

Exploration of miR-22 inhibiting cervical cancer progression through suppressing TGF-β/Smad3 pathway by targeting TGFBR1

class="figure-viewer-img"

Figure 4. The identification of miR-22 binding to TGFBR1 using dual luciferase reporters.